{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:57:51Z","timestamp":1786118271984,"version":"build-2736575974"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Melatonin is the most widely used sleep aid in children, yet no large study has examined its association with objective sleep architecture measured by polysomnography (PSG).<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess whether outpatient melatonin use is associated with differences in PSG-derived sleep architecture in a pediatric sleep clinic population.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cross-sectional, propensity score\u2013matched study used the Nationwide Children\u2019s Hospital Sleep DataBank, a deidentified dataset of PSG recordings and linked electronic health record data from children evaluated at a single academic pediatric sleep laboratory between 2017 and 2019. Children with at least 1 technically adequate PSG and complete electronic health record data were included; children older than 18 years were excluded. Data were analyzed from January to March 2026.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Outpatient melatonin prescription documented in the medication list.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The prespecified primary outcome was percentage of rapid eye movement (REM) sleep. Fourteen additional PSG parameters (sleep stages, respiratory indices, arousal index, periodic limb movements, oxygen desaturation index) were exploratory. Propensity score matching (1:1 nearest-neighbor, caliper 0.2 SD of the logit propensity score) on age, sex, body mass index percentile, comorbidity burden, obstructive sleep apnea, and epilepsy yielded 342 matched pairs (684 children). Outcomes were compared with 2-sided Wilcoxon signed-rank tests at \u03b1\u2009=\u2009.05; Benjamini\u2013Hochberg false discovery rate (FDR) correction was applied across the 15 outcomes.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The analytic cohort constituted 3392 children (mean [SD] age, 8.0 [5.0] years; 1924 male [56.7%]), including 346 melatonin users and 3046 nonusers. The matched cohort constituted 684 children (342 users and 342 nonusers). After matching, all 6 covariates achieved standardized mean differences below 0.10. Melatonin users had a lower median percentage of REM sleep than matched nonusers (16.7% [IQR, 11.6%-22.0%] vs 19.0% [IQR, 14.6%-23.2%]; Hedges\n g<\/jats:italic>\n \u2009=\u2009\u22120.22 [95% CI, \u22120.32 to \u22120.11]; FDR-corrected\n P<\/jats:italic>\n \u2009=\u2009.003). Total sleep time, sleep efficiency, non-REM sleep stages, respiratory indices, arousal index, periodic limb movements, and oxygen desaturation index did not differ (FDR-corrected\n P<\/jats:italic>\n \u2009&amp;gt;\u2009.05 for all 14 exploratory outcomes). The REM association was robust to 1:k matching (each melatonin user matched to 2 or 3 nonusers) and to averaging across repeated PSG nights. After adjusting for 3 psychiatric diagnoses (attention-deficit\/hyperactivity disorder, anxiety, depression), REM reduction was preserved with attenuated magnitude (16.6% [IQR, 11.6%-22.0%] vs 18.4% [IQR, 13.4%-22.8%]; Hedges\n g<\/jats:italic>\n \u2009=\u2009\u22120.17 [95% CI, \u22120.27 to \u22120.06];\n P<\/jats:italic>\n \u2009=\u2009.01).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cross-sectional study of 684 propensity score\u2013matched children, outpatient melatonin use was associated with a small reduction in REM sleep percentage and was not associated with differences in total sleep time, non-REM sleep stages, respiratory parameters, arousal architecture, or periodic limb movements. The REM association was attenuated when psychiatric diagnoses were added to the propensity model. Residual confounding cannot be excluded, and prospective studies with documented dose, timing, and adherence are needed to clarify the directionality of this association.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.26983","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:30:28Z","timestamp":1786030228000},"page":"e2626983","source":"Crossref","is-referenced-by-count":0,"title":["Melatonin Use and Polysomnographic Sleep Architecture in Children"],"prefix":"10.1001","volume":"9","author":[{"given":"Alen","family":"Juginovic","sequence":"first","affiliation":[{"name":"Department of Neurobiology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rodman","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine, University of Zagreb, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"1","key":"zoi260749r1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/jamapediatrics.2023.4749","article-title":"Characteristics of melatonin use among US children and adolescents.","volume":"178","author":"Hartstein","year":"2024","journal-title":"JAMA Pediatr"},{"issue":"1","key":"zoi260749r2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12967-019-1835-1","article-title":"Pediatric sleep disturbances and treatment with melatonin.","volume":"17","author":"Esposito","year":"2019","journal-title":"J Transl Med"},{"issue":"3","key":"zoi260749r3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.pcl.2011.03.011","article-title":"Pediatric insomnia.","volume":"58","author":"Owens","year":"2011","journal-title":"Pediatr Clin North Am"},{"issue":"10","key":"zoi260749r4","first-page":"1277","article-title":"Practice parameters for behavioral treatment of bedtime problems and night wakings in infants and young children.","volume":"29","author":"Morgenthaler","year":"2006","journal-title":"Sleep"},{"issue":"2","key":"zoi260749r5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ejpn.2014.12.007","article-title":"Current role of melatonin in pediatric neurology: clinical recommendations.","volume":"19","author":"Bruni","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"zoi260749r6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e6664","article-title":"Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial.","volume":"345","author":"Gringras","year":"2012","journal-title":"BMJ"},{"issue":"8","key":"zoi260749r7","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s10803-011-1418-3","article-title":"Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes.","volume":"42","author":"Malow","year":"2012","journal-title":"J Autism Dev Disord"},{"issue":"9","key":"zoi260749r8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1469-8749.2011.03980.x","article-title":"Melatonin in autism spectrum disorders: a systematic review and meta-analysis.","volume":"53","author":"Rossignol","year":"2011","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"zoi260749r9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrn2762","article-title":"The memory function of sleep.","volume":"11","author":"Diekelmann","year":"2010","journal-title":"Nat Rev Neurosci"},{"issue":"1-2","key":"zoi260749r10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0166-4328(95)00018-O","article-title":"A functional role for REM sleep in brain maturation.","volume":"69","author":"Marks","year":"1995","journal-title":"Behav Brain Res"},{"issue":"4","key":"zoi260749r11","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.chc.2009.04.009","article-title":"Pharmacologic treatment of pediatric insomnia.","volume":"18","author":"Owens","year":"2009","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"4","key":"zoi260749r12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.smrv.2010.11.003","article-title":"Serotonin control of sleep-wake behavior.","volume":"15","author":"Monti","year":"2011","journal-title":"Sleep Med Rev"},{"issue":"7","key":"zoi260749r13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1001\/jama.284.7.861","article-title":"Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men.","volume":"284","author":"Van Cauter","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"zoi260749r14","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.5664\/jcsm.5.2S.S6","article-title":"Regulation and functional correlates of slow wave sleep.","volume":"5","author":"Dijk","year":"2009","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"zoi260749r15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41597-022-01545-6","article-title":"A large collection of real-world pediatric sleep studies.","volume":"9","author":"Lee","year":"2022","journal-title":"Sci Data"},{"issue":"10","key":"zoi260749r16","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1093\/jamia\/ocy064","article-title":"The National Sleep Research Resource: towards a sleep data commons.","volume":"25","author":"Zhang","year":"2018","journal-title":"J Am Med Inform Assoc"},{"issue":"9596","key":"zoi260749r18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"zoi260749r19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jclinepi.2020.09.036","article-title":"PCORnet\u00ae 2020: current state, accomplishments, and future directions.","volume":"129","author":"Forrest","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"zoi260749r20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"3","key":"zoi260749r21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/jcpp.12469","article-title":"Annual Research Review: sleep problems in childhood psychiatric disorders\u2013a review of the latest science.","volume":"57","author":"Gregory","year":"2016","journal-title":"J Child Psychol Psychiatry"},{"issue":"1","key":"zoi260749r22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"issue":"2","key":"zoi260749r23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3102\/10769986006002107","article-title":"Distribution theory for Glass\u2019s estimator of effect size and related estimators.","volume":"6","author":"Hedges","year":"1981","journal-title":"J Educ Stat"},{"issue":"4","key":"zoi260749r24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value.","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"22","key":"zoi260749r25","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M","article-title":"A simple method for converting an odds ratio to effect size for use in meta-analysis.","volume":"19","author":"Chinn","year":"2000","journal-title":"Stat Med"},{"issue":"1","key":"zoi260749r26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.smrv.2004.04.003","article-title":"Melatonin as a hypnotic: pro.","volume":"9","author":"Zhdanova","year":"2005","journal-title":"Sleep Med Rev"},{"key":"zoi260749r17","volume-title":"The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Version 2.5","author":"Berry","year":"2018"},{"key":"zoi260749r27","volume-title":"Modern Epidemiology","author":"Rothman","year":"2008","edition":"3rd ed"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2852518\/juginovic_2026_oi_260749_1785439098.82473.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:30:30Z","timestamp":1786030230000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2852518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.26983","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}